Table 1.
CRT-HF Cohort (n=20) | Multimodality Cohort (n=27) | |
---|---|---|
Age, mean (SD), y | 58 ± 10 | 50 ± 15 |
Gender, No. (%) | ||
Male | 13 (65) | 16 (59) |
Female | 7 (35) | 11 (41) |
Cardiomyopathy, No. (%) | ||
Ischemic | 8 (40) | 8 (30) |
Nonischemic | 12 (60) | 19 (70) |
LVEF, mean (SD) | 0.23 (0.057) | 0.20 (0.066) |
QRSd, mean (SD), ms | 151 (26) | 138 (34) |
NYHA Class, No. (%) | ||
I | 0 (0) | 3 (11) |
II | 0 (0) | 12 (44) |
III | 20 (100) | 12 (44) |
IV | 0 (0) | 0 (0) |
Medication use, No. (%) | ||
Beta Blocker | 19 (90) | 26 (96) |
Amiodarone | 3 (15) | 1 (4) |
CRT-HF=Cardiac Resynchronization Therapy-Heart Failure
LVEF=left ventricular ejection fraction
QRSd = QRS duration
NYHA=New York Heart Association